İbrahim Petekkaya

511 total citations
24 papers, 382 citations indexed

About

İbrahim Petekkaya is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, İbrahim Petekkaya has authored 24 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in İbrahim Petekkaya's work include Cancer Risks and Factors (8 papers), Metabolism, Diabetes, and Cancer (5 papers) and Metastasis and carcinoma case studies (4 papers). İbrahim Petekkaya is often cited by papers focused on Cancer Risks and Factors (8 papers), Metabolism, Diabetes, and Cancer (5 papers) and Metastasis and carcinoma case studies (4 papers). İbrahim Petekkaya collaborates with scholars based in Türkiye, India and United States. İbrahim Petekkaya's co-authors include Kadri Altundağ, Taner Babacan, Mustafa Solak, Furkan Sarici, Neyran Kertmen, Özge Keskin, Fatma Paksoy Türköz, Zafer Arık, Yavuz Özışık and Emir Charles Roach and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Oral and Maxillofacial Surgery and Current Medical Research and Opinion.

In The Last Decade

İbrahim Petekkaya

23 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İbrahim Petekkaya Türkiye 10 261 121 111 83 49 24 382
Alexandra Tsigginou Greece 12 211 0.8× 110 0.9× 93 0.8× 64 0.8× 30 0.6× 19 366
Özge Keskin Türkiye 8 198 0.8× 120 1.0× 77 0.7× 50 0.6× 47 1.0× 25 306
Angela Chan Canada 10 195 0.7× 78 0.6× 72 0.6× 93 1.1× 38 0.8× 26 355
Yalun Li China 12 164 0.6× 89 0.7× 117 1.1× 163 2.0× 27 0.6× 39 412
Laura Iezzi Italy 11 308 1.2× 102 0.8× 76 0.7× 79 1.0× 20 0.4× 21 411
Valeria Forestieri Italy 10 387 1.5× 245 2.0× 85 0.8× 101 1.2× 78 1.6× 24 536
Valentina Sini Italy 13 242 0.9× 106 0.9× 63 0.6× 93 1.1× 53 1.1× 25 399
Kwan Chee Allen Chan Hong Kong 7 203 0.8× 169 1.4× 177 1.6× 85 1.0× 52 1.1× 8 545
A. Michelotti Italy 11 210 0.8× 108 0.9× 67 0.6× 100 1.2× 27 0.6× 15 372
Fredrika Killander Sweden 12 199 0.8× 240 2.0× 54 0.5× 73 0.9× 46 0.9× 25 411

Countries citing papers authored by İbrahim Petekkaya

Since Specialization
Citations

This map shows the geographic impact of İbrahim Petekkaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İbrahim Petekkaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İbrahim Petekkaya more than expected).

Fields of papers citing papers by İbrahim Petekkaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İbrahim Petekkaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İbrahim Petekkaya. The network helps show where İbrahim Petekkaya may publish in the future.

Co-authorship network of co-authors of İbrahim Petekkaya

This figure shows the co-authorship network connecting the top 25 collaborators of İbrahim Petekkaya. A scholar is included among the top collaborators of İbrahim Petekkaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İbrahim Petekkaya. İbrahim Petekkaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Petekkaya, İbrahim, Emir Charles Roach, Taner Babacan, et al.. (2019). Prognostic role of inflammatory biomarkers in metastatic breast cancer.. PubMed. 22(3). 614–622. 18 indexed citations
3.
Babacan, Taner, et al.. (2015). The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+ breast cancer patients.. PubMed. 20(1). 50–6. 11 indexed citations
4.
Petekkaya, İbrahim, et al.. (2015). Renal Cell Carcinoma Metastatic to the Tongue: A Case Report and Review of the Literature. Journal of Oral and Maxillofacial Surgery. 73(6). 1227–1230. 17 indexed citations
5.
Keskin, Özge, Sercan Aksoy, Taner Babacan, et al.. (2014). Impact of the obesity on lymph node status in operable breast cancer patients.. PubMed. 18(4). 824–30. 9 indexed citations
6.
Petekkaya, İbrahim, et al.. (2013). Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients.. PubMed. 17(4). 800–800. 1 indexed citations
7.
Türköz, Fatma Paksoy, Mustafa Solak, İbrahim Petekkaya, et al.. (2013). The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.. PubMed. 18(2). 335–41. 55 indexed citations
8.
Petekkaya, İbrahim, Uğur Şahin, Mustafa Solak, et al.. (2013). Association of breast cancer subtypes and body mass index.. PubMed. 99(2). 129–33. 14 indexed citations
9.
Boyraz, Bariş, Mehmet Alı Nahıt Şendur, Sercan Aksoy, et al.. (2013). Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer. Current Medical Research and Opinion. 29(4). 405–414. 67 indexed citations
10.
Türköz, Fatma Paksoy, Mustafa Solak, Sercan Aksoy, et al.. (2013). Association between family history and clinicopathologic characteristics in 1987 breast cancer patients: single institution experience from Turkey.. PubMed. 17(4). 649–57. 3 indexed citations
11.
Petekkaya, İbrahim, et al.. (2013). Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine.. PubMed. 17(4). 796–796. 1 indexed citations
12.
Sarici, Furkan, et al.. (2013). Colon involvement in a chronic lymphocytic leukemia patient.. PubMed. 18(1). 291–2. 1 indexed citations
13.
Petekkaya, İbrahim, Uğur Şahin, Mustafa Solak, et al.. (2013). Association of Breast Cancer Subtypes and Body Mass Index. Tumori Journal. 99(2). 129–133. 9 indexed citations
14.
Türköz, Fatma Paksoy, Mustafa Solak, İbrahim Petekkaya, et al.. (2012). Association between common risk factors and molecular subtypes in breast cancer patients. The Breast. 22(3). 344–350. 130 indexed citations
15.
Akpınar, Erhan, et al.. (2012). Fluid rim sign: a new sonographic sign of soft tissue aspergillosis. Diagnostic and Interventional Radiology. 19(3). 237–9. 3 indexed citations
16.
Kızılarslanoğlu, Muhammet Cemal, İbrahim Petekkaya, Taner Babacan, & Kadri Altundağ. (2012). Nine-weeks of adjuvant trastuzumab in HER2-positive breast cancer: A single center experience.. Journal of Clinical Oncology. 30(15_suppl). e11080–e11080. 1 indexed citations
17.
Doğan, Erkan, Hikmet Yorgun, İbrahim Petekkaya, et al.. (2012). Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience. Medical Oncology. 29(5). 3232–3239. 12 indexed citations
18.
Kızılarslanoğlu, Muhammet Cemal, et al.. (2012). Metabolic syndrome and breast cancer: an overview.. PubMed. 17(2). 223–9. 14 indexed citations
19.
Petekkaya, İbrahim, Çağatay Arslan, Erkan Doğan, et al.. (2011). Body mass index in breast cancer subtypes.. Journal of Clinical Oncology. 29(15_suppl). 1117–1117. 1 indexed citations
20.
Türköz, Fatma Paksoy, İbrahim Petekkaya, Çağatay Arslan, et al.. (2011). Association between blood groups and breast cancer subtype.. Journal of Clinical Oncology. 29(15_suppl). e11041–e11041. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026